UBS (UBS) Reports Strong Q2 2026 Results with +17% Profit Growth
Key Takeaways
- Net profit reached $2.8 billion in the second quarter, comfortably exceeding the analyst consensus estimate of $2.39 billion and rising 17% year over year.
- Global Wealth Management attracted $36 billion in net new assets, significantly outpacing analyst forecasts of roughly $21 billion, underscoring strong client confidence in the combined UBS–Credit Suisse franchise.
- The Investment Bank posted a record second-quarter performance, with pre-tax profit more than doubling to $1.2 billion, driven by surging equities trading and capital markets activity.
- A new $3 billion share buyback program was announced, with at least $1 billion expected to be repurchased over the next three months, following the completion of the prior $3 billion program in July.
- Cumulative cost savings from the Credit Suisse integration reached $12.6 billion, representing more than 90% of the $13.5 billion target, with the integration on track for substantial completion by year-end 2026.
- The internal workforce fell below 100,000 for the first time since the Credit Suisse acquisition, reflecting disciplined headcount management as legacy IT systems are decommissioned.
Earnings Context and Why It Matters
UBS Group AG's second-quarter 2026 results mark a pivotal moment in the bank's post-acquisition journey. Nearly three years after the government-brokered rescue of Credit Suisse, this earnings release provides the clearest evidence yet that the merger thesis is delivering on its promises. With integration milestones accelerating, cost savings materializing ahead of schedule, and client flows remaining robust, the quarter offered investors a tangible progress report on one of the most complex banking integrations in modern history. The results also arrive at a critical juncture for Swiss banking regulation, as Parliament deliberates on capital requirements that could materially shape UBS's future capital return capacity. For the market, this earnings report serves as a dual test: sustaining organic business momentum while navigating unresolved regulatory headwinds.
The Reported Numbers
UBS reported net profit attributable to shareholders of $2.8 billion for the second quarter of 2026, exceeding the company-provided analyst consensus of $2.39 billion. Earnings per share (EPS) came in at $0.87, while group revenue rose 16% year over year to $13.3 billion. Underlying pre-tax profit surged 45% to $3.9 billion, and the underlying return on CET1 capital reached 16.4%.
Global Wealth Management generated $2 billion in pre-tax profit, up 38% from the prior-year quarter, supported by $36 billion in net new assets. The Investment Bank delivered exceptional results with pre-tax profit of $1.2 billion — more than double the year-ago figure — on revenue of $3.7 billion, a 31% increase. Asset Management posted pre-tax profit of $237 million, up 9%, with assets under management surpassing $2.2 trillion. The Personal and Corporate Banking division contributed CHF 676 million in pre-tax profit, a 21% increase, while group credit loss expenses remained contained at CHF 61 million.
The bank's CET1 capital ratio stood at 14.4% at quarter-end, and the group's cost-to-income ratio improved to 70% on an underlying basis. Cumulative gross cost savings from the Credit Suisse integration reached $12.6 billion, placing UBS well within reach of its $13.5 billion target. Total invested assets across the group climbed to a record $7.3 trillion. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Market Reaction and Investor Sentiment
UBS shares rose approximately 1% to 3% in early trading following the results, with the stock trading near the upper end of its 52-week range. The positive but measured market reaction reflected a balance between strong underlying performance and lingering cautiousness around the pace of future capital returns. While net profit comfortably beat consensus, headline EPS of $0.87 fell slightly short of some third-party estimates, and revenue was broadly in line with or marginally below certain forecasts. Analysts at Vontobel noted that the earnings beat was concentrated in investment banking trading, with the other three operating divisions exceeding consensus by a narrower margin. Nonetheless, the $36 billion wealth management inflow — nearly double some analyst forecasts — and the new $3 billion buyback commitment were widely viewed as signals of confidence from management. Sentiment heading into the quarter had been cautiously optimistic, and the results largely validated that positioning, though unresolved Swiss capital regulation remains a key overhang for longer-term institutional investors.
Forward Outlook and Key Factors to Monitor
Looking ahead, UBS enters the second half of 2026 with several tailwinds and a few unresolved challenges. The most immediate catalyst for investors is the progress of Swiss parliamentary deliberations on capital requirements for systemically important banks, with the next key committee session scheduled for mid-August. The proposed framework could require UBS to hold an additional $20 billion or more in CET1 capital against its foreign subsidiaries — a requirement CEO Sergio Ermotti has publicly described as excessive and competitively damaging. Any softening of that stance by lawmakers would likely be received positively by the market and could unlock a faster pace of share buybacks beyond the newly announced $3 billion program.
On the operational side, the Credit Suisse integration is approaching its final chapter. With over 90% of legacy IT applications no longer in use and roughly 70% already fully decommissioned, UBS is targeting substantial completion by the end of 2026. Achieving this milestone would remove one of the largest execution risks that has hung over the stock since the 2023 acquisition.
Investors should also monitor wealth management flows in the Americas, where elevated advisor attrition has created pockets of client outflow. The division posted $1 billion in net inflows during Q2 even after a $10 billion seasonal tax-related outflow, offering early signs of stabilization. Meanwhile, management cautioned that geopolitical uncertainty, volatile energy prices, and potential shifts in inflation and interest rate expectations could create temporary headwinds in the third quarter, even as underlying client activity remains healthy and supportive of continued revenue growth. I reviewed recent patterns with Tickeron’s AI Real Time Patterns to gauge potential near-term moves.
Using Tickeron’s AI Screener in My Research
When evaluating financial names like this one, I often turn to Tickeron’s AI Screener to filter peers by metrics such as revenue growth, capital ratios, and AI signals. It helps me quickly spot how UBS stacks up against the broader sector without spending hours on manual screens.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
Momentum Indicator for UBS turns negative, indicating new downward trend
UBS saw its Momentum Indicator move below the 0 level on August 21, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned negative. In of the 76 cases, the stock moved further down in the following days. The odds of a decline are at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for UBS turned negative on July 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UBS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UBS advanced for three days, in of 347 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 322 cases where UBS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 20, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. UBS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.830) is normal, around the industry mean (1.897). UBS has a moderately high P/E Ratio (18.126) as compared to the industry average of (15.307). Projected Growth (PEG Ratio) (0.869) is also within normal values, averaging (1.603). Dividend Yield (0.021) settles around the average of (0.026) among similar stocks. P/S Ratio (3.392) is also within normal values, averaging (3.937).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a major bank
Industry MajorBanks
Advertisement